C.Q. Pharmaceutical Holding Co., Ltd. (SHE:000950)
China flag China · Delayed Price · Currency is CNY
4.890
-0.030 (-0.61%)
Nov 17, 2026, 3:04 PM CST

SHE:000950 Financials Overview

Millions CNY. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Jan '23 Dec '21
Revenue
80,50982,44780,56278,39767,82962,521
Revenue Growth
-3.09%2.34%2.76%15.58%8.49%38.26%
Gross Profit
5,4575,8335,9216,2355,7915,703
Operating Income
851.371,1321,2321,9572,1772,177
Net Income
323.24386.72282.99624.63952.281,005
Earnings Per Share
0.180.220.160.360.550.58
EPS Growth
-12.87%37.50%-55.56%-34.54%-5.17%13.73%

Revenue by Segment

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '24 Dec '23 Jan '23 Dec '21
Pharmaceutical Wholesale
77,87176,56075,15165,01460,088
Pharmaceutical Retail
4,1803,6953,0342,6432,266
Unallocated Other
396.6307.01212.62171.83166.87
Total
82,44780,56278,39767,82962,521

Cash & Debt

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Jan '23 Dec '21
Cash & Investments
4,5086,6849,3929,1497,4295,677
Total Debt
26,05523,69324,40323,17924,38420,054
Net Cash (Debt)
-21,547-17,009-15,012-14,030-16,955-14,377
Net Cash Growth
------
Net Cash Per Share
-12.26-9.68-8.49-8.09-9.79-8.29

Cash Flow & CapEx

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Jan '23 Dec '21
Operating Cash Flow
-292.01754.67-186.74508.53285.83250.16
Capital Expenditures
-327.68-299.54-250.53-244.41-268.07-489.55
Free Cash Flow
-619.69455.13-437.27264.1317.76-239.38
Free Cash Flow Growth
---1386.93%--

Margins

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Jan '23 Dec '21
Gross Margin
6.78%7.07%7.35%7.95%8.54%9.12%
Operating Margin
1.06%1.37%1.53%2.50%3.21%3.48%
Pretax Margin
0.71%0.81%0.69%1.23%2.17%2.53%
Profit Margin
0.40%0.47%0.35%0.80%1.40%1.61%
FCF Margin
-0.77%0.55%-0.54%0.34%0.03%-0.38%

Dividends

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingNov '26 Dec '25 Dec '24 Dec '23 Jan '23 Dec '21
Dividend Per Share
0.0600.0600.0600.0500.0600.105
Dividend Per Share Growth
0%0%20.00%-16.67%-42.86%-
Dividend Yield
1.23%1.02%1.11%1.01%1.18%2.00%

Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingNov '26 Dec '25 Dec '24 Dec '23 Jan '23 Dec '21
PE Ratio
26.5926.0132.8513.759.308.84
Forward PE
-11.8813.127.26--
P/FCF Ratio
-22.10-32.52498.57-
PS Ratio
0.100.120.120.110.130.14